Latest Market Access News

Elixir Energy wraps up Daydream-2 well operations and prepares for next appraisal in a strengthening gas market, while progressing farmout talks for Australian and Mongolian assets.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.

Constellation Resources reports promising drill results at its newly acquired Ularring Copper Gold Project and significantly expands its natural hydrogen exploration acreage in Western Australia, partnering with CSIRO to enhance prospectivity studies.

Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.

African Gold Ltd has had its trading suspension lifted following a formal response to ASX's price query and the release of new exploration results, signaling renewed market activity.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Zeus Resources Ltd has successfully reinstated its securities on the ASX and raised over $1.2 million through a Share Purchase Plan, Priority Options Offer, and Placement, advancing exploration in uranium, lithium, and rare earth projects across South Australia and Western Australia.

BauMart Holdings reports meaningful progress in expanding its distribution networks and strategic collaborations during the December 2024 quarter, positioning itself for growth across Indonesia, Australia, and the mining sector.

Brazilian Rare Earths Limited reports unprecedented ultra-high-grade rare earth intercepts and significant district-scale mineral discoveries at its Monte Alto project, alongside key permitting milestones advancing its mining ambitions.

BCI Minerals reports robust progress in its Mardie Salt and Potash Project, achieving financial close on a $981 million debt facility and advancing construction beyond the halfway mark. The company maintains a strong focus on sustainability and safety as it targets first salt shipment in Q2 FY27.

Microba Life Sciences reported a robust Q2 FY25 with revenue more than doubling year-on-year, driven by strong sales of its MetaXplore microbiome test in Australia and promising early adoption in the UK.

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.